New Results
Efficacy and safety of an mRNA-based RSV preF vaccine in preclinical studies
Huarong Bai, Qin Li, Yue Gao, Yubin Zhao, Xueliang Yu, View ORCID ProfileRongkuan Hu
doi: https://doi.org/10.1101/2024.09.29.615646
Huarong Bai
1Starna Therapeutics Co., Ltd., Suzhou, 215123, China
Qin Li
1Starna Therapeutics Co., Ltd., Suzhou, 215123, China
Yue Gao
1Starna Therapeutics Co., Ltd., Suzhou, 215123, China
Yubin Zhao
1Starna Therapeutics Co., Ltd., Suzhou, 215123, China
Xueliang Yu
1Starna Therapeutics Co., Ltd., Suzhou, 215123, China
Rongkuan Hu
1Starna Therapeutics Co., Ltd., Suzhou, 215123, China
Posted October 01, 2024.
Efficacy and safety of an mRNA-based RSV preF vaccine in preclinical studies
Huarong Bai, Qin Li, Yue Gao, Yubin Zhao, Xueliang Yu, Rongkuan Hu
bioRxiv 2024.09.29.615646; doi: https://doi.org/10.1101/2024.09.29.615646
Subject Area
Subject Areas
- Biochemistry (13174)
- Bioengineering (10018)
- Bioinformatics (32082)
- Biophysics (16529)
- Cancer Biology (13613)
- Cell Biology (19352)
- Clinical Trials (138)
- Developmental Biology (10460)
- Ecology (15518)
- Epidemiology (2067)
- Evolutionary Biology (19815)
- Genetics (13107)
- Genomics (18145)
- Immunology (13259)
- Microbiology (31028)
- Molecular Biology (12923)
- Neuroscience (67751)
- Paleontology (496)
- Pathology (2089)
- Pharmacology and Toxicology (3618)
- Physiology (5638)
- Plant Biology (11631)
- Synthetic Biology (3245)
- Systems Biology (7933)
- Zoology (1794)